National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -6 of 6         results per page
View Search Criteria | Help With Results
           
Last Modified: 11/2/2006     First Published: 10/6/2006  

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Biomarker/Laboratory analysis, Treatment


Active


18 and over


NCI


JHOC-J0658
7759, NCI-7759, JHOC-NA_00003114, NCT00387465


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


SNDX-275-0401
NCT00602030

Last Modified: 1/14/2009     First Published: 4/7/2006  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


NCI


ECOG-E1905
E1905, NCT00313586

Last Modified: 11/20/2008     First Published: 4/13/2007  

4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Biomarker/Laboratory analysis, Treatment


Active


18 and over


NCI


JHOC-NA_00006989
7605, NA_00006989, NCT00462605


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Pharmaceutical / Industry


SNDX-275-0301
NCT00676663


6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Biomarker/Laboratory analysis, Treatment


Active


18 and over


Pharmaceutical / Industry


SNDX-275-0302
NCT00754312

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov